 |
|
 |
|
|
recently in the press Spectros Corporation Signs Distribution Agreements in Middle EastPORTOLA VALLEY, Calif., December 1, 2011/PRNewswire/ -- Spectros Corporation announced today an expansion of its distribution channels in the Middle East region partnering with AccuVis Bio, a Science and Technology Company from the UAE. This group will join other distributors already selling Spectros products outside of the U.S. Goodwin Biotechnology Announces a Collaboration with Spectros CorporationPLANTATION, Fla. and PORTOLA VALLEY, Calif., Oct. 24, 2011 /PRNewswire/ -- Goodwin Biotechnology, Inc. (GBI) and Spectros Corporation jointly announced a collaboration for the process development and cGMP manufacturing of an antibody: dye conjugate that will be used in Phase I and Phase II clinical trials.
Spectros T-Stat Shown to Be Earliest Available Method for Detection of Surgical Skin Flap Compromise After SurgeryPORTOLA VALLEY, Calif., Oct. 3, 2011 /PRNewswire/ -- In an independent study published in the Journal of Reconstructive Microsurgery, researchers at the University of Texas Health Science Center San Antonio have found that the Spectros T-Stat® oximeter responds earliest to compromised blood flow during reconstructive microsurgery when compared clinically to other available monitors.
Spectros Corporation Signs Distribution Agreements in Korea, Switzerland, DenmarkPORTOLA VALLEY, Calif., August 31, 2011/PRNewswire/ -- Spectros, developer and manufacturer of the T-Stat VLS Tissue Oximeter announces its success in the reconstructive plastic surgery market. Spectros Corporation announced today an expansion of its distribution channels in Europe and Asia with the signing of 3 new distributors based in Korea, Switzerland, and Denmark. These groups
Spectros Year-to-Date Revenue Up 51% in First Half of 2011PORTOLA VALLEY, Calif., July 29, 2011/PRNewswire/ -- Spectros Corporation announced today that 2011 year-to-date sales revenue rose 51% (year-over-year) over the similar period in 2010. This continues the third year in a row for double-digit revenue growth for Spectros since the current T-Stat Tissue Oximeter product line was launched in 2008. “This growth sends a clear signal that the market is embracing the Spectros state-of-the-art broadband VLS tissue oximetry,” notes CFO John Bagnatori. Spectros T-Stat® and Continuüm® Tissue Oximeters are the only broadband tissue oximeters on the market in the U.S. and Europe.
Spectros Corporation Introduces Continuum®, a BroadbandInfrared Sensor for Brain and Gut OximetryPORTOLA VALLEY, Calif., June 13, 2011 -- /PRNewswire/ -- Spectros Corporation announced Continuum®, a proprietary broadband near infrared illuminator sensor under development for several years and now in testing. This sensor represents the newest generation and state-of-the-art for medical sensor probes. Continuum is a solid-state illuminator that creates light of many wavelengths, called broadband, which allows for noninvasive analysis of various components in tissue and blood, including different types of hemoglobin, fat content, and water content. The new sensor is protected by a broad family of issued patents, and will be incorporated into the Company's flagship T-Stat Oximeter and Analysis platforms. Spectros Corporation Sales and Licensing Revenue Up 32% in 2010PORTOLA VALLEY, Calif., Feb. 10, 2011 /PRNewswire/ -- Spectros Corporation announces that sales and licensing revenue rose 32% (year-over-year) in 2010. This is the third year in a row for double-digit revenue growth for Spectros since the current T-Stat product line was launched in 2008. Spectros released certain 2010 financial results to shareholders today...
Spectros White LED Patent Scope Affirmed In U.S. Patent Office Reexamination
PORTOLA VALLEY, Calif., Dec. 21, 2010 /PRNewswire/ -- A core Spectros white LED patent was validated during reexamination by the United States Patent Office, and will reissue next year. In a reexamination of U.S. Patent No. 6,711,426, the Patent Office has affirmed that Spectros' use of White LEDs in medical spectroscopy is unique and protectable, and that certain other applications in biomedical and industrial spectroscopy devices also fall under this Spectros patent...
Spectros Presents New Clinical Studies Using T-Stat VLS Tissue Oximeter at Anesthesiology 2010PORTOLA VALLEY, Calif., Nov. 2, 2010 /PRNewswire/ -- Spectros Corporation presented new clinical results using tissue oxygen saturation with the T-Stat VLS Tissue Oximeter at the San Diego Convention Center during Anesthesiology 2010. This newly released data was presented during poster sessions entitled "Experimental Circulation: Ischemia and Reperfusion" and "Clinical Circulation: Pharmacology/Physiology", held at the American Society of Anesthesiologists (ASA 2010) on October 16, 2010 in San Diego, CA. The studies were both conducted at Loma Linda University Medical Center in Loma Linda, CA...
Spectros Attended The American Society of Plastic Surgeons (ASPS) Plastic Surgery 2010 in Toronto at the Metro Toronto Convention Centre, October 1-5, 2010PORTOLA VALLEY, Calif., Oct. 12 /PRNewswire/ -- Spectros, developer and manufacturer of the T-Stat VLS Tissue Oximeter announces its success in the reconstructive plastic surgery market... Spectros Presents at the Pediatric Academic Societies (PAS) National Conference 2009Spectros (Portola Valley, CA) announced today that its T-Stat Tissue Oximeter was featured  |